Splenectomy in hematology : does it still have a place in the management of primary immune thrombocytopenia?

Esplenectomía en hematología : ¿sigue teniendo lugar en el manejo de la trombocitopenia inmune primaria?

Main Article Content

Carmen Rosales
Virginia Abello

Downloads

Download data is not yet available.

Article Details

Author Biographies (SEE)

Carmen Rosales, Clínica de Marly ; Fundación Universitaria de Ciencias de la Salud (FUCS)

Departamento de Hematología y Unidad de Trasplante de Médula Ósea, Clínica de Marly (Bogotá, Colombia). Hospital de San José, Fundación Universitaria de Ciencias de la Salud (FUCS) (Bogotá, Colombia).

Virginia Abello, Clínica de Marly ; Fundación Universitaria de Ciencias de la Salud (FUCS)

Departamento de Hematología y Unidad de Trasplante de Médula Ósea, Clínica de Marly (Bogotá, Colombia). Hospital de San José, Fundación Universitaria de Ciencias de la Salud (FUCS) (Bogotá, Colombia).

References

Baccarani U, Terrosu G, Donini A, Zaja F, Bresadola F, Baccarani M. Splenectomy in hematology. Current practice and new perspectives. Haematologica. 1999;84(5):431-6.

Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104(9):2623-34.

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Eficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371(9610):395-403.

Bussel JB, Kuter DJ, Pullarkat V, Lyons RM, Guo M, Nichol JL. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood. 2009;113(10):2161-71.

Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373(9664):641-8.

Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146(1):25-33.

OJS System - Metabiblioteca |